Dronabinol, Cannabidiol

6 trials 3 recruiting NNeurology/Psychiatry

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

1 Completed trials

6 Sponsors

5 Countries

Phase III

Phase II

Phase III: 2 Phase II: 4

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Tuberous sclerosis complex 1

Sponsors using this IMP

Azienda Ospedaliero-Universitaria Maggiore Della Carita 1 Ferraz Lynce Especialidades Farmaceuticas S.A. 1 IRCCS Istituto Nazionale Tumori Fondazione Pascale 1 Oils4cure S.L. 1 Universitaetsklinikum Schleswig-Holstein AöR 1 Universitair Medisch Centrum Utrecht 1

All trials

6 total

MEDICAL CANNABIS TREATMENT IN NEURODEGENERATIVE DISEASES (NEUROBIS) Pending

2023-507715-35-02 Phase II 1 country Azienda Ospedaliero-Universitaria Maggiore Della Carita
Cannabis extrAct in oncology Patients for the treatment of TUmor Related symptom burden (CAPTURE) Pending

2024-519568-42-00 Phase II 1 country IRCCS Istituto Nazionale Tumori Fondazione Pascale
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach Recruiting

2023-507843-12-01 Phase III 1 country Universitair Medisch Centrum Utrecht
A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ … Recruiting

2024-520287-34-01 Phase II 1 country Ferraz Lynce Especialidades Farmaceuticas S.A.
Treatment of difficult-to-control epilepsy associated with tuberous sclerosis complex Recruiting

2024-520171-27-00 Phase III 1 country Oils4cure S.L.
Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO) Ended

2024-518917-24-00 Phase II 1 country Universitaetsklinikum Schleswig-Holstein AöR

Showing 1–6 of 6 trials

← All drugs A–Z